FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Continuous Renal Replacement Therapy (CRRT) Solutions
Status: Currently in Shortage
»Date first posted: 04/22/2020
»Therapeutic Categories: Renal

Expand all

Baxter Healthcare (Reverified 05/04/2020)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
PrismaSol BK0/0/1.2 Replacement Solution for Continuous Renal Replacement Therapy, NON-PVC. (NDC 24571-113-06) Available - backorders due to COVID-19-related demand Demand increase for the drug
PrismaSol BGK0/2.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-108-06) Available - backorders due to COVID-19-related demand Demand increase for the drug
PrismaSol BGK4/0/1.2 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (DC 24571-114-06) Available - backorders due to COVID-19-related demand Demand increase for the drug
PrismaSol BGK4/2.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-105-06) Available - backorders due to COVID-19-related demand Demand increase for the drug
PrismaSol BGK2/3.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-103-06) Available - backorders due to COVID-19-related demand Demand increase for the drug
PrismaSol BGK2/0 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-102-06) Available - backorders due to COVID-19-related demand Demand increase for the drug
PrismaSol B22GK4/0 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-111-06) Available - backorders due to COVID-19-related demand Demand increase for the drug
PHOXILLUM BK4/2.5 Replacement Solution for Continuous Renal Replacement Therapy (NDC 24571-116-06) Available - backorders due to COVID-19-related demand Demand increase for the drug
PHOXILLUM B22K4/0 Replacement Solution for Continuous Renal Replacement Therapy (NDC 24571-117-06) Available - backorders due to COVID-19-related demand Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English